Unravel the complexities of ADC development and production with a leading CDMO powered by Pfizer
With over 20 years of experience and specialist support, Pfizer CentreOne is ready to help streamline your antibody-drug conjugate (ADC) journey from clinical to commercialization.
Our therapeutic expertise, commitment to quality and end-to-end capabilities for drug substance and drug product – from cytotoxic compound synthesis and drug substance intermediates to sterile fill and finish – we’re ready to help bring your therapeutic to patients.
Learn how our ADC capabilities can support you at every stage. Because time is life.
Get the one-pager.